Abstract
Summary: Glutaric aciduria type I is an inborn error of organic acid metabolism that demonstrates a particular temporal vulnerability (acute encephalopathic episodes in infancy) and a spatial vulnerability (acute striatal necrosis, focused on the putamen). Excitotoxic mechanisms involving 3-hydroxyglutaric acid as the major neurotoxin have been suggested. This paper proposes a role for metabolites of the kynurenine pathway in the pathogenic process and modifies the hypothesis of Heyes. Deficiency of glutaryl-CoA dehydrogenase blocking the glutarate pathway and activation of indoleamine 2,3-dioxygenase in macrophages/monocytes by intercurrent inflammation may increase flux down the kynurenine pathway towards the production of quinolinic acid. Quinolinic acid is neurotoxic and is an endogenous agonist at N-methyl-D-aspartate receptors. Synergistic excitation of these receptors by quinolinic acid and 3-hydroxyglutaric acid, which alone does not have sufficient potency, may be involved in the pathogenesis of striatal necrosis.
Similar content being viewed by others
REFERENCES
Bender DA (1983)Biochemistry of try tophan in health and disease.Mol Aspects Med 6:101-197.
Beninger RJ, Colton AM, Ingles JL, Jhamandas K, Boegman RJ (1994)Picolinic acid blocksthe neurotoxic but not the neuroexcitant properties of quinolinic acid in the rat brain:evidence from turning behaviour and tyrosine hydroxylase immunohistochemistry. Neuroscience 61:603-612.
Bennett JP Jr, Logan WJ, Snyder SH (1973)Amino acids as central nervous transmitters:the influence of ions,amino acid analogues,and ontogeny on trans ort systems for L-glutamicand L-aspartic acids and glycine into central nervous synaptosomes of the rat.J Neurochem 21:1533-1550.
Birch PJ, Grossman CJ, Hayes AG (1988)Kynurenic acid antagonises res onses to NMDAvia an action at the strychnine-insensitive glycine receptor.Eur J Pharmacol 154: 85-87.
Cao H, Pietrak BL, Grubmeyer C (2002)Quinolinate phosphoribosyltransferase:kinetic mechanism for a type II PRTase.Biochemistry 41:3520-3528.
Chiarugi A, Meli E, Moroni F (2001)Similarities and differences in the neuronal death pro-cesses activated by 3OH-kynurenine and quinolinic acid.JNeurochem 77:1310-1318.
de Mello CF, Kolker S, Ahlemeyer B, et al (2001)Intrastriatal administration of 3-hydroxyglutaric acid induces convulsions and striatal lesions in rats.Brain Res 916: 70-75.
Fukui S, Schwarcz R, Rapoport SI, Takada Y, Smith QR (1991)Blood-brain barrier trans-port of kynurenines:implications for brain synthesis and metabolism.J Neurochem 56:2007-2017.
Goodman SI, Frerman FE (2001)Organic acidemias due to defects in lysine oxidation:2-ketoadipic acidemia and glutaric acidemia.In:Scriver CR, Beaudet AL, Sly WS, Valle D,eds;Childs B,Kinzler KW,Vogelstein B,assoc eds.The Metabolic and MolecularBases of Inherited Disease, 8th edn.New York: McGraw-Hill,2195-2204.
Goodman SI, Norenberg MD, Shikes RH, Breslich DJ, Moe PG (1977)Glutaric aciduria:biochemical and morphologic considerations.JPediatr 90: 746-750.
Greenberg CR, Duncan AM, Gregory CA, Singal R, Goodman SI (1994)Assignment ofhuman glutaryl-CoA dehydrogenase gene (GCDH)to the short arm of chromosome 19(19p13.2)by in situ hybridization and somatic cell hybrid analysis.Genomics 21:289-290.
Guillemin GJ, Kerr SJ, Smythe GA, et al (2001)Kynurenine athway metabolism in human astrocytes:a paradox for neuronal protection.J Neurochem 78:842-853.
Hankes LV, Brown RR, Lippincott S, Schmaeler M(1967)Effects of L-tryptophan load on the metabolism of tryptophan-2-C 14 in man.J Lab Clin Med 69:313-324.
Heyes MP (1987)Hy othesis:a role for quinolinic acid in the neuropathology of glutaric aciduria type I.Can J Neurol Sci 14-(supplement 3):441-443.
Heyes MP, Achim CL, Wiley CA, Major EO, Saito K, Markey SP (1996)Human microglia convert L-tryptophan into the neurotoxin quinolinic acid.Biochem J 320:595-597.
Kim JP, Choi DW (1987)Quinolinate neurotoxicity in cortical cell culture.Neuroscience 23:423-432.
Koeller DM, Woontner M, Crnic LS, et al (2002)Biochemical,athologic and behavioral analysis of a mouse model of glutaric acidemia type I.Hum Mol Genet 11:347-357.
Kölker S, Ahlemeyer B, Krieglstein J, Hoffmann GF (2000)Maturation-dependent neurotoxicity of 3-hydroxyglutaric and glutaric acids in vitro:a new athophysiologic a proach to glutaryl-CoA dehydrogenase de ficiency.Pediatr Res 47:495-503.
Kölker S, Kohr G, Ahlemeyer B, et al (2002)Ca(2 + )andNa( + )dependence of 3-hydroxyglutarate-induced excitotoxicity in primary neuronal cultures from chick embryo telencephalons.Pediatr Res 52:199-206.
Kölker S, Hoffmann GF, Schor DSM, et al (2003)Glutaryl-CoA dehydrogenase de ficiency:region-speci fic analysis of organic acids and acylcarnitines in post mortem brain redicts vulnerability of the utamen.Neuropediatrics 34:253-260.
Kölker S, Koeller DM, Okun JG, Hoffmann GF (2004)Pathomechanisms of neurodegeneration in glutaryl-CoA dehydrogenase de ficiency.Ann Neurol 55:7-12.
Leibel RL, Shih VE, Goodman SI, et al (1980)Glutaric acidemia:a metabolic disorder causing progressive choreoathetosis.Neurology 30:1163-1168.
McDonald JW, Silverstein FS, Johnston MV (1988)Neurotoxicity of N-methyl-D-aspartate is markedly enhanced in developing rat central nervous system.Brain Res 459:200-203.
McDonald JW, Behrens MI, Chung C, Bhattacharyya T, Choi DW (1997)Susceptibility to a optosis is enhanced in immature cortical neurons.Brain Res 759:228-232.
Monyer H, Burnashev N, Laurie DJ, Sakmann B, Seeburg PH (1994)Developmental and regional expression in the rat brain and functional properties of four NMDA receptors.Neuron 12:529-540.
Nasu S, Yamaguchi K, Sakakibara S, Imai H, Ueda I (1981)The effect of pyrazines on the metabolism of try tophan and nicotinamide adenine dinucleotide in the rat.Evidence of the formation of a potent inhibitor of aminocarboxy-muconate-semialdehyde decarboxylase from yrazinamide.Biochim Biophys Acta 677:109-119.
Okuda S, Nishiyama N, Saito H, Katsuki H (1998)3-Hydroxykynurenine,an endogenous oxidative stress generator,causes neuronal cell death with a optotic features and region selectivity.J Neurochem 70:299-307.
Perkins MN, Stone TW (1982)An iontophoretic investigation of the actions of convulsant kynurenines and their interaction with the endogenous excitant quinolinic acid.Brain Res 247:184-187.
Porciúncula LO, Dal Pizzol A, Coitinho AS, Emanuelli T, Souza DO, Wajner M (2000)Inhibition of syna tosomal [H-3 ]glutamate uptake and [H-3 ]glutamate binding to lasma membranes from brain of young rats by glutaric acid in vitro.JNeurolSci 173:93-96.
Portera-Cailliau C, Price DL, Martin LJ (1996)N-methyl-D-as artate receptor proteins NR2A and NR2B are differentially distributed in the developing rat central nervous system as revealed by subunit-speci fic antibodies.J Neurochem 66:692-700.
Schwarcz R, Whetsell WO Jr, Mangano RM (1983)Quinolinic acid:an endogenous metabolite that produces axon-sparing lesions in rat brain.Science 219:316-318.
Stone TW (2001)Kynurenines in the CNS:from endogenous obscurity to therapeutic importance.Prog Neurobiol 64:185-218.
Stone TW, Perkins MN (1981)Quinolinic acid:a potent endogenous excitant at amino acid receptors in CNS.Eur J Pharm 72:411-412.
Strauss KA, Puffenberger EG, Robinson DL, Holmes Morton-D (2003)Type I glutaric aciduria,art 1:Natural history of 77 atients.Am J Med Genet Part C:Semin Med Genet 121C:38-52.
Ullrich K, Flott-Rahmel B, SchluffP, et al (1999)Glutaric aciduria ty e I:pathomechanisms of neurodegeneration.JInheritMetabDis 22:392-403.
Wenzel A, Fritschy JM, Mohler H, Benke D (1997)NMDA rece tor heterogeneity during postnatal development of the rat brain:differential expression of the NR2A,NR2B, and NR2C subunit roteins.J Neurochem 68:469-478.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Varadkar, S., Surtees, R. Glutaric aciduria type I and kynurenine pathway metabolites: A modified hypothesis. J Inherit Metab Dis 27, 835–842 (2004). https://doi.org/10.1023/B:BOLI.0000045767.42193.97
Issue Date:
DOI: https://doi.org/10.1023/B:BOLI.0000045767.42193.97